![](/img/cover-not-exists.png)
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males
Patrick G. Clay, Maqual R. Graham, Cameron C. Lindsey, Kenneth C. Lamp, Collin Freeman, Alan GlarosVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/j.amjopharm.2004.09.006
File:
PDF, 767 KB
english, 2004